Terns Pharmaceuticals, Inc. ($TERN)
Filing Information
| Accession Number | 0001872564-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
414,441
Total Value
$2,818,226.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 21,551 | $4.64 | $99,996.64 | 60,315 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 150,000 | โ | โ | 210,315 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 5, 2026 | Sale | 71,339 | $38.10 | $2,718,229.92 | 138,976 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 21,551 | $0.00 | $0.00 | 1,053,449 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Jan 5, 2026 | Exercise/Conversion | 150,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |